|
Acuvax Limited - Company Profile Snapshot
| Company Profile: |
Acuvax Limited |
| Ticker: |
ACU |
| Exchanges: |
SYD |
| 2009 Sales: |
n/a |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
AUSTRALIA |
| Employees: |
7 |
Business Description
Acuvax Limited Formerly known as Avantogen Limited. The Group's principal activities are researching and developing cancer therapies. It is also involved in virus and vaccine development through its acquisition of Hawaii Biotech. It is active in the field of biotechnology, namely oncology therapeutics and nutraceutical development and commercialization. The Group develops vaccines against infectious diseases such as Dengue, seasonal flu and West Nile Virus. It operates in Australia and in the United States of America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
